• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS T4; RADIOIMMUNOASSAY, TOTAL THYROXINE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS T4; RADIOIMMUNOASSAY, TOTAL THYROXINE Back to Search Results
Catalog Number 12017709122
Device Problem High Test Results (2457)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 03/13/2014
Event Type  malfunction  
Event Description
The customer received questionable results for thyroxine (t4), thyrotropin (tsh), and t-uptake (t-up) on one patient sample, and erroneous t4 results on a second patient when testing was performed on cobas e411 rack instrument with serial number (b)(4).Patient 1 had erroneous t4, tsh and t-up results that were reported outside of the laboratory, with no adverse events.These results were reported on the mdr with submission number 1823260-2014-02769.Please see the attachment to the mdr for a copy of these results.No further samples for patient 1 could be provided for evaluation; therefore a specific root cause could not be identified.Patient 2 had erroneous t4 results that were reported outside of the laboratory, with no adverse events.These data were reported on the mdrs with submission numbers 1823260-2014-02769 and 1823260-2014-02770.Please see the attachment to the mdr for a copy of these results.A specific root cause could not be identified.On (b)(6) 2014, patient 2 returned and had a new sample drawn, which generated erroneous t4 results on this instrument and another instrument.The t4 result from this instrument was 21.7 ug/dl, which was reported to the physician.On (b)(6) 2014, the sample was sent to a sister facility and was run on a cobas 6000 e601 instrument and generated a result of 20.0 ug/dl.The sample was then sent to another laboratory where it was run on a siemens instrument and generated a result of 12.7 ug/dl.The customer believed the results from the other methodology to be correct.There was no adverse event.The customer believes the erroneous results are due to some interference in the sample and refused a service dispatch.The (b)(6) 2014 sample from patient 2 was requested for further evaluation.
 
Manufacturer Narrative
It was unknown if the initial reporter sent report to the fda.
 
Manufacturer Narrative
On follow up with the customer, they indicated that patient 2 is taking a vitamin d supplement and birth control pills.The patient also had additional thyroid results that were generated on this instrument on (b)(6) 2014.The patient had a "t3" result of 184 ng/dl, a t-uptake result of 1.5 tbi, a tsh result of 0.263 uiu/ml and a "t4, free" result of 1.5 ng/dl.(b)(6).
 
Manufacturer Narrative
The investigation determined that no interfering factors seemed to be present in the investigated sample.It was also determined that no interference from pharmaceuticals seemed to be present either.A general reagent issue was excluded.The difference between the elecsys and other assays could possibly be attributed to differences in methods and instruments, differences in standardization and applications and different antibodies.
 
Manufacturer Narrative
Additional testing was performed during the investigation on the sample for patient 2: anti-tg: 58.02 iu/ml anti-tpo: 86.69 iu/ml.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
T4
Type of Device
RADIOIMMUNOASSAY, TOTAL THYROXINE
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250
Manufacturer (Section G)
ROCHE DIAGNOSTICS GMBH
sandhoferstrasse 116
na
mannheim (baden-wurttemberg) 6830 5
GM   68305
Manufacturer Contact
michael leslie
9115 hague road
na
indianapolis, IN 46250
3175214343
MDR Report Key3816208
MDR Text Key4451035
Report Number1823260-2014-03479
Device Sequence Number1
Product Code CDX
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K961490
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,User Facility
Reporter Occupation Health Professional
Type of Report Initial,Followup,Followup,Followup
Report Date 07/28/2014
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received05/16/2014
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date01/31/2015
Device Catalogue Number12017709122
Device Lot Number17416501
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Event Location Laboratory
Date Manufacturer Received04/23/2014
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
PATIENT 2 - APRI; PATIENT 2 - PROPRANOLOL HCL 10 MG; PATIENT 2 - SPIRONOLACTONE 150 MG
-
-